At the Epworth Centre for Immunotherapies and Snowdome Laboratories, we lead ground-breaking research to change the face of blood cancer treatment forever.
Unlike other cancers, blood cancer rates are going up in Australia. Projections for 2021 showed blood cancers as the second-most diagnosed cancers in Australia. Sadly, blood cancers have a significant mortality rate. They were estimated as the second leading cause of cancer-related deaths in 20211-2.
Epworth HealthCare and the Snowdome Foundation share a vision to give hope to people living with blood cancer and their families. We’re working together to give the very best care and accelerate new treatment options for blood cancers.
This Centre falls under the governance of the Epworth Cancer Services Clinical Institute.
Blood cancers in Australia
Our objectives are to:
- Increase access to and quality of blood cancer treatments delivered at Epworth.
- Contribute to global progress of blood cancer treatments through translational investigator-initiated research and clinical trials.
- Provide access to CAR T-cell therapies via clinical trials and ultimately as standard of care treatments.
- Support academic education and clinical expertise.
- Australian Institute of Health and Welfare, Cancer summary data visualisation: All blood cancers combined, 2021, accessed 8 July 2021
- Leukaemia Foundation, National report confirms incidence of blood cancer continues to rise in Australia, 9 June 2021, accessed 8 July 2021
Our achievements to date
Patients accessed treatment through clinical trials
Clinically-impactful genomic tests for Epworth patients
Patient biospecimens collected, for research studies to advance cancer knowledge in the future